Overview

Prevention of Contrast-Induced Nephropathy

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Patients with pre-existing kidney disease are at high risk of acute renal failure when exposed to radio-contrast dyes, for example during a cardiac angiogram. The investigators hypothesize that an infusion of saline + furosemide + mannitol will reduce rates of contrast-induced nephropathy when compared with saline infusion controls.
Phase:
N/A
Details
Lead Sponsor:
University of Alberta
Collaborator:
Alberta Heritage Foundation for Medical Research
Treatments:
Furosemide
Mannitol